Wenyue Zhang1, Philip M James2, Bobby G Ng3, Xueli Li4, Baoyun Xia1, Jiang Rong1, Ghazia Asif1, Kimiyo Raymond5, Melanie A Jones1, Madhuri Hegde1, Tongzhong Ju4, Richard D Cummings6, Katie Clarkson5, Tim Wood7, Cornelius F Boerkoel8, Hudson H Freeze3, Miao He9. 1. Department of Human Genetics and. 2. Division of Genetics, Department of Medicine, Children's Hospital Boston, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA; 3. Human Genetics Program, Sanford Children's Health Research Center, Sanford-Burnham Medical Research Institute, La Jolla, CA; 4. Palmieri Metabolic Disease Laboratory, Children's Hospital of Philadelphia, Philadelphia, PA; 5. Mayo Biochemical Genetics Laboratory, Mayo Medical School, Rochester, MN; 6. Department of Biochemistry, Emory University, Atlanta, GA; 7. Greenwood Genetics Center, Greenwood, SC; 8. Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada; 9. Palmieri Metabolic Disease Laboratory, Children's Hospital of Philadelphia, Philadelphia, PA; Department of Pathology and Laboratory of Medicine, University of Pennsylvania, Philadelphia, PA. hem@email.chop.edu.
Abstract
BACKGROUND: Primary deficiencies in mannosylation of N-glycans are seen in a majority of patients with congenital disorders of glycosylation (CDG). We report the discovery of a series of novel N-glycans in sera, plasma, and cultured skin fibroblasts from patients with CDG having deficient mannosylation. METHOD: We used LC-MS/MS and MALDI-TOF-MS analysis to identify and quantify a novel N-linked tetrasaccharide linked to the protein core, an N-tetrasaccharide (Neu5Acα2,6Galβ1,4-GlcNAcβ1,4GlcNAc) in plasma, serum glycoproteins, and a fibroblast lysate from patients with CDG caused by ALG1 [ALG1 (asparagine-linked glycosylation protein 1), chitobiosyldiphosphodolichol β-mannosyltransferase], PMM2 (phosphomannomutase 2), and MPI (mannose phosphate isomerase). RESULTS: Glycoproteins in sera, plasma, or cell lysate from ALG1-CDG, PMM2-CDG, and MPI-CDG patients had substantially more N-tetrasaccharide than unaffected controls. We observed a >80% decline in relative concentrations of the N-tetrasaccharide in MPI-CDG plasma after mannose therapy in 1 patient and in ALG1-CDG fibroblasts in vitro supplemented with mannose. CONCLUSIONS: This novel N-tetrasaccharide could serve as a diagnostic marker of ALG1-, PMM2-, or MPI-CDG for screening of these 3 common CDG subtypes that comprise >70% of CDG type I patients. Its quantification by LC-MS/MS may be useful for monitoring therapeutic efficacy of mannose. The discovery of these small N-glycans also indicates the presence of an alternative pathway in N-glycosylation not recognized previously, but its biological significance remains to be studied.
BACKGROUND:Primary deficiencies in mannosylation of N-glycans are seen in a majority of patients with congenital disorders of glycosylation (CDG). We report the discovery of a series of novel N-glycans in sera, plasma, and cultured skin fibroblasts from patients with CDG having deficient mannosylation. METHOD: We used LC-MS/MS and MALDI-TOF-MS analysis to identify and quantify a novel N-linked tetrasaccharide linked to the protein core, an N-tetrasaccharide (Neu5Acα2,6Galβ1,4-GlcNAcβ1,4GlcNAc) in plasma, serum glycoproteins, and a fibroblast lysate from patients with CDG caused by ALG1 [ALG1 (asparagine-linked glycosylation protein 1), chitobiosyldiphosphodolichol β-mannosyltransferase], PMM2 (phosphomannomutase 2), and MPI (mannose phosphate isomerase). RESULTS: Glycoproteins in sera, plasma, or cell lysate from ALG1-CDG, PMM2-CDG, and MPI-CDGpatients had substantially more N-tetrasaccharide than unaffected controls. We observed a >80% decline in relative concentrations of the N-tetrasaccharide in MPI-CDG plasma after mannose therapy in 1 patient and in ALG1-CDG fibroblasts in vitro supplemented with mannose. CONCLUSIONS: This novel N-tetrasaccharide could serve as a diagnostic marker of ALG1-, PMM2-, or MPI-CDG for screening of these 3 common CDG subtypes that comprise >70% of CDG type I patients. Its quantification by LC-MS/MS may be useful for monitoring therapeutic efficacy of mannose. The discovery of these small N-glycans also indicates the presence of an alternative pathway in N-glycosylation not recognized previously, but its biological significance remains to be studied.
Authors: Baoyun Xia; James A Royall; Gautam Damera; Goverdhan P Sachdev; Richard D Cummings Journal: Glycobiology Date: 2005-04-15 Impact factor: 4.313
Authors: Sharita Timal; Alexander Hoischen; Ludwig Lehle; Maciej Adamowicz; Karin Huijben; Jolanta Sykut-Cegielska; Justyna Paprocka; Ewa Jamroz; Francjan J van Spronsen; Christian Körner; Christian Gilissen; Richard J Rodenburg; Ilse Eidhof; Lambert Van den Heuvel; Christian Thiel; Ron A Wevers; Eva Morava; Joris Veltman; Dirk J Lefeber Journal: Hum Mol Genet Date: 2012-04-05 Impact factor: 6.150
Authors: Catharina Steentoft; Sergey Y Vakhrushev; Hiren J Joshi; Yun Kong; Malene B Vester-Christensen; Katrine T-B G Schjoldager; Kirstine Lavrsen; Sally Dabelsteen; Nis B Pedersen; Lara Marcos-Silva; Ramneek Gupta; Eric Paul Bennett; Ulla Mandel; Søren Brunak; Hans H Wandall; Steven B Levery; Henrik Clausen Journal: EMBO J Date: 2013-04-12 Impact factor: 11.598
Authors: Baoyun Xia; Christa L Feasley; Goverdhan P Sachdev; David F Smith; Richard D Cummings Journal: Anal Biochem Date: 2009-02-10 Impact factor: 3.365
Authors: Jie Chen; Xueli Li; Andrew Edmondson; Gail Ditewig Meyers; Kosuke Izumi; Amanda M Ackermann; Eva Morava; Can Ficicioglu; Michael J Bennett; Miao He Journal: Clin Chem Date: 2019-02-15 Impact factor: 8.327
Authors: Bobby G Ng; Sergey A Shiryaev; Daisy Rymen; Erik A Eklund; Kimiyo Raymond; Martin Kircher; Jose E Abdenur; Fusun Alehan; Alina T Midro; Michael J Bamshad; Rita Barone; Gerard T Berry; Jane E Brumbaugh; Kati J Buckingham; Katie Clarkson; F Sessions Cole; Shawn O'Connor; Gregory M Cooper; Rudy Van Coster; Laurie A Demmer; Luisa Diogo; Alexander J Fay; Can Ficicioglu; Agata Fiumara; William A Gahl; Rebecca Ganetzky; Himanshu Goel; Lyndsay A Harshman; Miao He; Jaak Jaeken; Philip M James; Daniel Katz; Liesbeth Keldermans; Maria Kibaek; Andrew J Kornberg; Katherine Lachlan; Christina Lam; Joy Yaplito-Lee; Deborah A Nickerson; Heidi L Peters; Valerie Race; Luc Régal; Jeffrey S Rush; S Lane Rutledge; Jay Shendure; Erika Souche; Susan E Sparks; Pamela Trapane; Amarilis Sanchez-Valle; Eric Vilain; Arve Vøllo; Charles J Waechter; Raymond Y Wang; Lynne A Wolfe; Derek A Wong; Tim Wood; Amy C Yang; Gert Matthijs; Hudson H Freeze Journal: Hum Mutat Date: 2016-03-21 Impact factor: 4.878
Authors: Sandra Brasil; Carlota Pascoal; Rita Francisco; Dorinda Marques-da-Silva; Giuseppina Andreotti; Paula A Videira; Eva Morava; Jaak Jaeken; Vanessa Dos Reis Ferreira Journal: Int J Mol Sci Date: 2018-04-27 Impact factor: 5.923
Authors: Daniel L Polla; Andrew C Edmondson; Sandrine Duvet; Michael E March; Ana Berta Sousa; Anna Lehman; Dmitriy Niyazov; Fleur van Dijk; Serwet Demirdas; Marjon A van Slegtenhorst; Anneke J A Kievit; Celine Schulz; Linlea Armstrong; Xin Bi; Daniel J Rader; Kosuke Izumi; Elaine H Zackai; Elisa de Franco; Paula Jorge; Sophie C Huffels; Marina Hommersom; Sian Ellard; Dirk J Lefeber; Avni Santani; Nicholas J Hand; Hans van Bokhoven; Miao He; Arjan P M de Brouwer Journal: Am J Hum Genet Date: 2021-06-17 Impact factor: 11.025
Authors: Jacqueline Alexander; April M Teague; Jing Chen; Christopher E Aston; Yuet-Kin Leung; Steven Chernausek; Rebecca A Simmons; Sara E Pinney Journal: PLoS One Date: 2018-02-22 Impact factor: 3.752